Search

everythinglearnresearchcommunity

for

Search:↓

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Platelet-rich plasma may help with hair growth and skin quality but more research is needed to confirm its effectiveness.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

The study found that family history, personal history of adolescent acne, no pregnancies, hirsutism, office work, stress, and low intake of fruits/vegetables and fish are risk factors for adult female acne.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

DA liposomes with chloramphenicol effectively target hair follicles and combat MRSA with minimal skin toxicity.

Using fat stem cells and blood cell-rich plasma together improves healing in diabetic wounds by affecting cell signaling.

Fractional resurfacing is safe and effective for certain skin conditions in Asian patients, but care must be taken to avoid skin pigmentation issues.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Platelet-rich plasma might help with skin aging, ulcers, and hair loss, but more research is needed to prove its effectiveness and safety.

Injectable gelatin microspheres with platelet-rich plasma speed up wound healing.

New technologies help us better understand how skin microbes affect skin diseases.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Trichoepitheliomas can be hard to distinguish from other skin conditions and often start in teenage years.

The study identified the top 10 most important areas for future hair loss research.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Serum formulations were better at delivering molecules to the hair bulb than nanoparticles.

More research is needed to understand and manage rheumatoid arthritis better.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.